Sex differences in outcomes of total hip arthroplasty for the treatment of ankylosing spondylitis

• Published in: Chinese medical journal Vol. 134; no. 21; pp. 2641 - 2643
• Main Authors: Zhang, Liang, Li, Hong-Chao, Man, Si-Liang, Bian, Tao, Dou, Yong, Liu, Wei, Zhou, Yi-Xin
• Format: Journal Article
• Language: English
• Published: China Lippincott Williams & Wilkins 13.10.2021; Lippincott Williams & Wilkins Ovid Technologies; Department of Adult Joint Reconstructive Surgery, Beijing Jishuitan Hospital, Fourth Clinical College of Peking University, Jishuitan Orthopaedic College of Tsinghua University, Beijing 100035, China%Department of Rheumatology, Beijing Jishuitan Hospital, Fourth Clinical College of Peking University, Jishuitan Orthopaedic College of Tsinghua University, Beijing 100035, China; Wolters Kluwer
• Subjects: Arthritis; Arthroplasty, Replacement, Hip; Body mass index; Correspondence; Demographics; Disease; Female; Females; Gender differences; Hemoglobin; Hip Joint - surgery; Hip Prosthesis; Humans; Inflammatory bowel disease; Joint replacement surgery; Joint surgery; Laboratories; Male; Pain; Patients; Range of motion; Sex Characteristics; Spondylitis, Ankylosing - surgery; Standard deviation; Treatment Outcome
• DOI: 10.1097/CM9.0000000000001782
• ISSN: 0366-6999; 2542-5641

The objectives of this study were to determine: (1) whether there were significant differences between female and male AS patients on baseline patient demographics, clinical, and laboratory characteristics and (2) whether gender affected outcomes following THA on AS patients significantly. The study was approved by the Institutional Research Ethics Committee of Beijing Jishuitan Hospital (No. 202004-83). Descriptive analysis of categorical variables was presented in the form of percentages and frequencies, and descriptive analysis of continuous variables was shown as mean and standard deviation or median and quartile (25%–75%) if the data were skewed. On the contrary, it was generally recognized that female AS patients showed a higher disease burden concerning disease activity and pain scores, including BASDAI, BASFI, and quality of life.